GRAIL, Inc. (NASDAQ:GRAL) is one of the stocks Jim Cramer put under the spotlight recently. Cramer noted the company’s huge run for the year and stated: “And there’s Grail, a company that has a blood test that can detect cancer, maybe. It’s just got a readout for how the test works, and the results were mixed to positive. Grail immediately took advantage of the huge spike on the news… to do a private placement of $325 million. Now, I’m intrigued by the technology, but the company’s been losing hundreds of ...